Evidence Details for SNCAIP
Basic Information Top
Gene Symbol: | SNCAIP ( MGC39814,SYPH1,Sph1 ) |
---|---|
Gene Full Name: | synuclein, alpha interacting protein |
Band: | 5q23.2 |
Quick Links | Entrez ID:9627; OMIM: 603779; Uniprot ID:SNCAP_HUMAN; ENSEMBL ID: ENSG00000064692; HGNC ID: 11139 |
Relate to Another Database: | SFARIGene; denovo-db |
Sequences Top
>SNCAIP|9627|nucleotide
ATGGAAGCCCCTGAATACCTTGATTTGGATGAAATTGACTTTAGTGATGACATATCTTATTCAGTCACATCACTCAAGACGATCCCAGAACTGTGCCGAAGATGT
GATACGCAAAACGAAGACAGATCAGTTTCTAGCTCTAGCTGGAATTGTGGCATCTCAACTCTTATTACAAACACGCAAAAGCCCACAGGAATCGCTGATGTGTAC
AGTAAGTTCCGCCCAGTGAAGCGGGTTTCGCCACTGAAACATCAGCCAGAGACTCTGGAGAACAATGAAAGTGATGACCAAAAGAACCAGAAAGTGGTTGAGTAC
CAGAAAGGGGGTGAGTCTGACCTGGGCCCCCAGCCTCAGGAGCTTGGCCCTGGAGATGGAGTGGGCGGCCCACCAGGTAAGAGCTCTGAGCCCAGCACATCGCTG
GGTGAACTGGAGCACTACGACCTCGACATGGATGAGATTCTGGATGTGCCTTATATTAAATCCAGTCAGCAGCTTGCCTCTTTTACCAAGGTGACTTCAGAAAAA
AGAATTTTGGGCTTATGCACAACCATCAATGGCCTTTCTGGCAAAGCCTGCTCTACAGGAAGTTCTGAGAGCTCATCATCCAACATGGCACCATTTTGTGTTCTT
TCTCCCGTGAAAAGCCCTCACTTGAGAAAAGCATCAGCTGTCATCCACGACCAGCACAAGCTGTCCACTGAAGAAACCGAGATCTCACCTCCTCTGGTTAAATGT
GGCTCTGCATATGAGCCTGAAAACCAGAGTAAAGACTTCCTAAACAAGACATTTAGTGATCCTCATGGTCGAAAAGTTGAGAAGACAACACCAGACTGCCAGCTC
AGGGCCTTCCACCTACAATCCTCAGCAGCAGAATCCAAACCAGAAGAGCAGGTCAGTGGCCTAAACCGGACCAGCTCCCAAGGCCCAGAAGAAAGGAGTGAGTAT
CTGAAAAAAGTGAAAAGCATCTTGAACATTGTTAAAGAAGGACAGATCTCTCTCCTGCCACACCTAGCTGCAGACAATCTAGACAAAATTCACGACGAAAATGGA
AACAATCTATTACATATTGCGGCGTCACAGGGACACGCAGAGTGTCTACAGCACCTCACTTCTTTGATGGGAGAAGACTGCCTCAATGAGCGCAACACTGAGAAG
Show »
ATGGAAGCCCCTGAATACCTTGATTTGGATGAAATTGACTTTAGTGATGACATATCTTATTCAGTCACATCACTCAAGACGATCCCAGAACTGTGCCGAAGATGT
GATACGCAAAACGAAGACAGATCAGTTTCTAGCTCTAGCTGGAATTGTGGCATCTCAACTCTTATTACAAACACGCAAAAGCCCACAGGAATCGCTGATGTGTAC
AGTAAGTTCCGCCCAGTGAAGCGGGTTTCGCCACTGAAACATCAGCCAGAGACTCTGGAGAACAATGAAAGTGATGACCAAAAGAACCAGAAAGTGGTTGAGTAC
CAGAAAGGGGGTGAGTCTGACCTGGGCCCCCAGCCTCAGGAGCTTGGCCCTGGAGATGGAGTGGGCGGCCCACCAGGTAAGAGCTCTGAGCCCAGCACATCGCTG
GGTGAACTGGAGCACTACGACCTCGACATGGATGAGATTCTGGATGTGCCTTATATTAAATCCAGTCAGCAGCTTGCCTCTTTTACCAAGGTGACTTCAGAAAAA
AGAATTTTGGGCTTATGCACAACCATCAATGGCCTTTCTGGCAAAGCCTGCTCTACAGGAAGTTCTGAGAGCTCATCATCCAACATGGCACCATTTTGTGTTCTT
TCTCCCGTGAAAAGCCCTCACTTGAGAAAAGCATCAGCTGTCATCCACGACCAGCACAAGCTGTCCACTGAAGAAACCGAGATCTCACCTCCTCTGGTTAAATGT
GGCTCTGCATATGAGCCTGAAAACCAGAGTAAAGACTTCCTAAACAAGACATTTAGTGATCCTCATGGTCGAAAAGTTGAGAAGACAACACCAGACTGCCAGCTC
AGGGCCTTCCACCTACAATCCTCAGCAGCAGAATCCAAACCAGAAGAGCAGGTCAGTGGCCTAAACCGGACCAGCTCCCAAGGCCCAGAAGAAAGGAGTGAGTAT
CTGAAAAAAGTGAAAAGCATCTTGAACATTGTTAAAGAAGGACAGATCTCTCTCCTGCCACACCTAGCTGCAGACAATCTAGACAAAATTCACGACGAAAATGGA
AACAATCTATTACATATTGCGGCGTCACAGGGACACGCAGAGTGTCTACAGCACCTCACTTCTTTGATGGGAGAAGACTGCCTCAATGAGCGCAACACTGAGAAG
Show »
>SNCAIP|9627|protein
MEAPEYLDLDEIDFSDDISYSVTSLKTIPELCRRCDTQNEDRSVSSSSWNCGISTLITNTQKPTGIADVYSKFRPVKRVSPLKHQPETLENNESDDQKNQKVVEY
QKGGESDLGPQPQELGPGDGVGGPPGKSSEPSTSLGELEHYDLDMDEILDVPYIKSSQQLASFTKVTSEKRILGLCTTINGLSGKACSTGSSESSSSNMAPFCVL
SPVKSPHLRKASAVIHDQHKLSTEETEISPPLVKCGSAYEPENQSKDFLNKTFSDPHGRKVEKTTPDCQLRAFHLQSSAAESKPEEQVSGLNRTSSQGPEERSEY
LKKVKSILNIVKEGQISLLPHLAADNLDKIHDENGNNLLHIAASQGHAECLQHLTSLMGEDCLNERNTEKLTPAGLAIKNGQLECVRWMVSETEAIAELSCSKDF
PSLIHYAGCYGQEKILLWLLQFMQEQGISLDEVDQDGNSAVHVASQHGYLGCIQTLVEYGANVTMQNHAGEKPSQSAERQGHTLCSRYLVVVETCMSLASQVVKL
Show »
MEAPEYLDLDEIDFSDDISYSVTSLKTIPELCRRCDTQNEDRSVSSSSWNCGISTLITNTQKPTGIADVYSKFRPVKRVSPLKHQPETLENNESDDQKNQKVVEY
QKGGESDLGPQPQELGPGDGVGGPPGKSSEPSTSLGELEHYDLDMDEILDVPYIKSSQQLASFTKVTSEKRILGLCTTINGLSGKACSTGSSESSSSNMAPFCVL
SPVKSPHLRKASAVIHDQHKLSTEETEISPPLVKCGSAYEPENQSKDFLNKTFSDPHGRKVEKTTPDCQLRAFHLQSSAAESKPEEQVSGLNRTSSQGPEERSEY
LKKVKSILNIVKEGQISLLPHLAADNLDKIHDENGNNLLHIAASQGHAECLQHLTSLMGEDCLNERNTEKLTPAGLAIKNGQLECVRWMVSETEAIAELSCSKDF
PSLIHYAGCYGQEKILLWLLQFMQEQGISLDEVDQDGNSAVHVASQHGYLGCIQTLVEYGANVTMQNHAGEKPSQSAERQGHTLCSRYLVVVETCMSLASQVVKL
Show »
Evidence summary Top
Click the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default.
Evidences | Syndromic Gene | GWAS | CNV | Linkage | Association | Expression | NGS de novo | NGS Mosaic | NGS Other | Low-Scale Gene Studies | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Score (No. of Studies) | No | 0 (1) | 0 (0) | 1 (1) | 0 (0) | 0 (0) | 0 (2) | 1 (1) | 0 (0) | 0 (0) | 3 (5) |
Syndromic Autism Gene Top
Genome-Wide Association Studies (By Ethnic Group) Top
Family Based Association Studies: 1
Reference | Stage | Platform | #Families | Affecteds | Result | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
#Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Age (range) |
IQ (range) |
||||||
CAUCASIAN | |||||||||||
Hussman, 2011_1 | Discovery | Illumina Infinium Human 1 M beadship | 597 | - (-) | ASD | - - |
- - |
Case Control Based Association Studies: 0
Reference | Stage | Platform | ASD Cases | Normal Controls | Result | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
#Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Age (range) |
IQ | #Subjects (% Women) |
Age (range) |
|||||
No Evidence. |
CNV Studies Top
Linkage Studies Top
Reference | Source | Method | ADI-R | ADOS | Diagnosis | Family | Individual | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Simplex | Multiplex | Control | Affected | Control | Total | ||||||
Ma, 2007 | USA | SNP-based genomic screen | autism | 26 | - | 26 | - | - | - | - |
Low Scale Association Studies (by Ethnic Group) Top
Large Scale Expression Studies Top
NGS de novo Mutation Studies Top
Reference | Case Number | Family Number | de novo Number | Title |
---|---|---|---|---|
De Rubeis S, 2014 | 2270 | - | 1702 | Synaptic, transcriptional and chromatin genes disrupted in autism |
NGS Mosaic SNV Studies Top
Reference | Case Number | Family Number | Mosaic Number | Title |
---|---|---|---|---|
Dou Y, 2017 | - | 2361 | 230 | Postzygotic single-nucleotide mosaicisms contribute to the etiology of autism spectrum disorder and |
NGS Other Studies Top
Low Scale Gene Studies Top
Contact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.